Brief: Peptonic Medical Q1 Operating Loss Widens To SEK 3.2 Mln
May 15 (Reuters) - Peptonic Medical AB PMED.TE :
* INTERIM REPORT PERIOD FROM JANUARY 2019 TO MARCH 2019
* Q1 NET SALES OF PRODUCTS KSEK 1,470 (0)
* Q1 GROSS PROFIT KSEK 802 (0), GROSS MARGIN 55% (0%)
* Q1 OPERATING LOSS KSEK -3,185 (-2,756)
Source text for Eikon: ID:nWkr9llwBS
Further company coverage: PMED.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts